Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD.11.1667854300143.1551
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD.7.188712725592.1581
Domestic EquitiesCIPLA LTD.5.755849000073.7891
Domestic EquitiesDIVI LABORATORIES LTD.5.575410496571.4759
Domestic EquitiesAUROBINDO PHARMA LTD.5.444861510069.8015
Domestic EquitiesFORTIS HEALTHCARE LTD.5.299485510067.9377
Domestic EquitiesLUPIN LTD.4.584130324058.7679
Domestic EquitiesASTER DM HEALTHCARE LTD.4.449595699157.0414
Domestic EquitiesWOCKHARDT LTD.3.675027487147.1129
Domestic EquitiesALKEM LABORATORIES LTD.2.89917524937.1655
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD.2.860966612136.6766
Domestic EquitiesMETROPOLIS HEALTHCARE LTD.2.417418163630.9907
Domestic EquitiesDR REDDYS LABORATORIES LTD.2.117721155527.1489
Domestic EquitiesDR. LAL PATH LABS LTD.1.91328771124.5266
Domestic EquitiesAJANTA PHARMA LTD.1.90229473724.3863
Domestic EquitiesTORRENT PHARMACEUTICALS LTD.1.88557092124.1713
Domestic EquitiesFDC LTD.1.792147128322.9750
Domestic EquitiesMEDI ASSIST HEALTHCARE SERVICES LTD.1.738741867022.2900
Domestic EquitiesKRISHNA INSTITUTE OF MEDICAL SCIENCES LTD.1.720532745222.0572
Domestic EquitiesINDOCO REMEDIES LTD.1.652466699221.1837
Domestic EquitiesIPCA LABORATORIES LTD.1.544314245219.7980
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD.1.437345518718.4260
Domestic EquitiesJUPITER LIFE LINE HOSPITALS LTD.1.242610638915.9296
Domestic EquitiesAKUMS DRUGS AND PHARMACEUTICALS LTD1.175225735215.0654
Domestic EquitiesCOROMANDEL INTERNATIONAL LTD.1.17256000015.0312
Domestic EquitiesZYDUS LIFESCIENCES LTD.1.060113728713.5907
Domestic EquitiesNIVA BUPA HEALTH INSURANCE COMPANY LTD.0.9568150000012.2655
Domestic EquitiesSANOFI INDIA LTD.0.95251916412.2103
Domestic EquitiesACUTAAS CHEMICALS LTD.0.892710000011.4440
Domestic EquitiesSANOFI CONSUMER HEALTHCARE INDIA LTD.0.85151916410.9158
Domestic EquitiesMEDPLUS HEALTH SERVICES LTD.0.838211880810.7462
Domestic EquitiesMANKIND PHARMA LTD0.7500414469.6146
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD.0.7339160009.4088
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD.0.6498245888.3307
Domestic EquitiesORCHID PHARMA LTD.0.64081150008.2145
Domestic EquitiesSYNGENE INTERNATIONAL LTD.0.53351070466.8392
Domestic EquitiesINVENTURUS KNOWLEDGE SOLUTIONS LTD.0.5243417426.7209
Domestic EquitiesDEEPAK NITRITE LTD.0.2776179093.5587
Domestic EquitiesLAXMI DENTAL LIMITED0.0487143570.6237
Total 92.3211 1183.5452
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET7.3647 94.4147
Cash & Cash Equivalents and Net AssetsA) REPO0.3142 4.0277
Total 7.6789 98.4424
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.